The global market for Oligonucleotide Purification Column was valued at US$ 141 million in the year 2024 and is projected to reach a revised size of US$ 231 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Oligonucleotide purification columns are a chromatographic tool used to separate and purify synthetic oligonucleotides (short-chain DNA or RNA fragments). They are usually based on fillers such as silica membranes or ion exchange resins. They quickly remove impurities (such as short fragments, salt ions or unreacted reagents) through centrifugation or vacuum operations. They are widely used in molecular biology, gene synthesis, and diagnostic reagent preparation.
North American market for Oligonucleotide Purification Column is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oligonucleotide Purification Column is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Oligonucleotide Purification Column include Agilent, Waters, Qiagen, Thermo Fisher, Hamilton, ADS Biotec, GL Sciences, SUZHOU NANOMICRO TECHNOLOGY, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Purification Column, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Purification Column.
The Oligonucleotide Purification Column market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotide Purification Column market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide Purification Column manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Agilent
Waters
Qiagen
Thermo Fisher
Hamilton
ADS Biotec
GL Sciences
SUZHOU NANOMICRO TECHNOLOGY
Segment by Type
cHPLC Columns
UHPLC Columns
Others
Segment by Application
Molecular Biology Research
Gene Synthesis and Editing
Drug Development and Nucleic Acid Therapeutics
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide Purification Column manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oligonucleotide Purification Column in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Oligonucleotide Purification Column Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 Oligonucleotide Purification Column by Type
1.2.1 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 cHPLC Columns
1.2.3 UHPLC Columns
1.2.4 Others
1.3 Oligonucleotide Purification Column by Application
1.3.1 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Molecular Biology Research
1.3.3 Gene Synthesis and Editing
1.3.4 Drug Development and Nucleic Acid Therapeutics
1.3.5 Others
1.4 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Oligonucleotide Purification Column Revenue 2020-2031
1.4.2 Global Oligonucleotide Purification Column Sales 2020-2031
1.4.3 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oligonucleotide Purification Column Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Oligonucleotide Purification Column Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global Oligonucleotide Purification Column Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global Oligonucleotide Purification Column Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oligonucleotide Purification Column, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oligonucleotide Purification Column, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oligonucleotide Purification Column, Product Type & Application
2.7 Global Key Manufacturers of Oligonucleotide Purification Column, Date of Enter into This Industry
2.8 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest Oligonucleotide Purification Column Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global Oligonucleotide Purification Column Company Type and Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Scenario by Region
3.1 Global Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oligonucleotide Purification Column Sales by Region: 2020-2031
3.2.1 Global Oligonucleotide Purification Column Sales by Region: 2020-2025
3.2.2 Global Oligonucleotide Purification Column Sales by Region: 2026-2031
3.3 Global Oligonucleotide Purification Column Revenue by Region: 2020-2031
3.3.1 Global Oligonucleotide Purification Column Revenue by Region: 2020-2025
3.3.2 Global Oligonucleotide Purification Column Revenue by Region: 2026-2031
3.4 North America Oligonucleotide Purification Column Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oligonucleotide Purification Column Sales by Country (2020-2031)
3.4.3 North America Oligonucleotide Purification Column Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oligonucleotide Purification Column Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oligonucleotide Purification Column Sales by Country (2020-2031)
3.5.3 Europe Oligonucleotide Purification Column Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oligonucleotide Purification Column Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oligonucleotide Purification Column Sales by Region (2020-2031)
3.6.3 Asia Pacific Oligonucleotide Purification Column Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oligonucleotide Purification Column Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oligonucleotide Purification Column Sales by Country (2020-2031)
3.7.3 Latin America Oligonucleotide Purification Column Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oligonucleotide Purification Column Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Oligonucleotide Purification Column Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oligonucleotide Purification Column Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oligonucleotide Purification Column Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oligonucleotide Purification Column Sales by Type (2020-2031)
4.1.1 Global Oligonucleotide Purification Column Sales by Type (2020-2025)
4.1.2 Global Oligonucleotide Purification Column Sales by Type (2026-2031)
4.1.3 Global Oligonucleotide Purification Column Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global Oligonucleotide Purification Column Revenue by Type (2020-2031)
4.2.1 Global Oligonucleotide Purification Column Revenue by Type (2020-2025)
4.2.2 Global Oligonucleotide Purification Column Revenue by Type (2026-2031)
4.2.3 Global Oligonucleotide Purification Column Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global Oligonucleotide Purification Column Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oligonucleotide Purification Column Sales by Application (2020-2031)
5.1.1 Global Oligonucleotide Purification Column Sales by Application (2020-2025)
5.1.2 Global Oligonucleotide Purification Column Sales by Application (2026-2031)
5.1.3 Global Oligonucleotide Purification Column Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global Oligonucleotide Purification Column Revenue by Application (2020-2031)
5.2.1 Global Oligonucleotide Purification Column Revenue by Application (2020-2025)
5.2.2 Global Oligonucleotide Purification Column Revenue by Application (2026-2031)
5.2.3 Global Oligonucleotide Purification Column Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global Oligonucleotide Purification Column Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agilent
6.1.1 Agilent Company Information
6.1.2 Agilent Description and Business Overview
6.1.3 Agilent Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agilent Oligonucleotide Purification Column Product Portfolio
6.1.5 Agilent Recent Developments/Updates
6.2 Waters
6.2.1 Waters Company Information
6.2.2 Waters Description and Business Overview
6.2.3 Waters Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Waters Oligonucleotide Purification Column Product Portfolio
6.2.5 Waters Recent Developments/Updates
6.3 Qiagen
6.3.1 Qiagen Company Information
6.3.2 Qiagen Description and Business Overview
6.3.3 Qiagen Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qiagen Oligonucleotide Purification Column Product Portfolio
6.3.5 Qiagen Recent Developments/Updates
6.4 Thermo Fisher
6.4.1 Thermo Fisher Company Information
6.4.2 Thermo Fisher Description and Business Overview
6.4.3 Thermo Fisher Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Thermo Fisher Oligonucleotide Purification Column Product Portfolio
6.4.5 Thermo Fisher Recent Developments/Updates
6.5 Hamilton
6.5.1 Hamilton Company Information
6.5.2 Hamilton Description and Business Overview
6.5.3 Hamilton Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hamilton Oligonucleotide Purification Column Product Portfolio
6.5.5 Hamilton Recent Developments/Updates
6.6 ADS Biotec
6.6.1 ADS Biotec Company Information
6.6.2 ADS Biotec Description and Business Overview
6.6.3 ADS Biotec Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ADS Biotec Oligonucleotide Purification Column Product Portfolio
6.6.5 ADS Biotec Recent Developments/Updates
6.7 GL Sciences
6.7.1 GL Sciences Company Information
6.7.2 GL Sciences Description and Business Overview
6.7.3 GL Sciences Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GL Sciences Oligonucleotide Purification Column Product Portfolio
6.7.5 GL Sciences Recent Developments/Updates
6.8 SUZHOU NANOMICRO TECHNOLOGY
6.8.1 SUZHOU NANOMICRO TECHNOLOGY Company Information
6.8.2 SUZHOU NANOMICRO TECHNOLOGY Description and Business Overview
6.8.3 SUZHOU NANOMICRO TECHNOLOGY Oligonucleotide Purification Column Sales, Revenue and Gross Margin (2020-2025)
6.8.4 SUZHOU NANOMICRO TECHNOLOGY Oligonucleotide Purification Column Product Portfolio
6.8.5 SUZHOU NANOMICRO TECHNOLOGY Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oligonucleotide Purification Column Industry Chain Analysis
7.2 Oligonucleotide Purification Column Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oligonucleotide Purification Column Production Mode & Process Analysis
7.4 Oligonucleotide Purification Column Sales and Âé¶¹Ô´´ing
7.4.1 Oligonucleotide Purification Column Sales Channels
7.4.2 Oligonucleotide Purification Column Distributors
7.5 Oligonucleotide Purification Column Customer Analysis
8 Oligonucleotide Purification Column Âé¶¹Ô´´ Dynamics
8.1 Oligonucleotide Purification Column Industry Trends
8.2 Oligonucleotide Purification Column Âé¶¹Ô´´ Drivers
8.3 Oligonucleotide Purification Column Âé¶¹Ô´´ Challenges
8.4 Oligonucleotide Purification Column Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Agilent
Waters
Qiagen
Thermo Fisher
Hamilton
ADS Biotec
GL Sciences
SUZHOU NANOMICRO TECHNOLOGY
Ìý
Ìý
*If Applicable.